Rybelsus (semaglutide) is a GLP-1 receptor agonist that stimulates insulin secretion, suppresses glucagon release, and slows gastric emptying to control blood glucose in type 2 diabetes
HenningssonMBrundinMScheffelTEdinCViolaFCarlhllCJ
Instead, the interest is mostly indirect: GLP-1s may help with weight, insulin resistance, and inflammation, which can shape the metabolic environment in which hormone receptor-positive breast cancers develop or recur
The animal data, however, has been remarkably consistent and genuinely promising: Tendon and ligament healing : In rat models of Achilles tendon rupture, animals treated with BPC-157 showed significantly improved biomechanical outcomes (including greater failure load and tissue stiffness) within 10 to 14 days compared to untreated controls
10.1016/j.psyneuen.2019.104554 46
The Danish Registry of Diabetic Retinopathy